Follow
Cedric Shuai Cui
Cedric Shuai Cui
Other namesShuai Cui
Postdoctoral Research Fellow in Pharmacology, immunology and Neuroscience, The University of
Verified email at uq.edu.au
Title
Cited by
Cited by
Year
Intrinsic bias at non-canonical, β-arrestin-coupled seven transmembrane receptors
S Pandey, P Kumari, M Baidya, R Kise, Y Cao, H Dwivedi-Agnihotri, ...
Molecular cell 81 (22), 4605-4621. e11, 2021
732021
CD8+ lineage dendritic cells determine adaptive immune responses to inflammasome activation upon sterile skin injury
R Chakraborty, J Chandra, S Cui, L Tolley, MA Cooper, M Kendall, ...
Experimental Dermatology 27 (1), 71-79, 2018
122018
Development of potent and selective agonists for complement C5a receptor 1 with in vivo activity
DM Gorman, XX Li, JD Lee, JN Fung, CS Cui, HS Lee, BE Rolfe, ...
Journal of Medicinal Chemistry 64 (22), 16598-16608, 2021
102021
In vivo pharmacodynamic method to assess complement C5a receptor antagonist efficacy
CS Cui, V Kumar, DM Gorman, RJ Clark, JD Lee, TM Woodruff
ACS Pharmacology & Translational Science 5 (1), 41-51, 2021
42021
Development of Synthetic Human and Mouse C5a: Application to Binding and Functional Assays In Vitro and In Vivo
DM Gorman, XX Li, CD Payne, CS Cui, JD Lee, KJ Rosengren, ...
ACS Pharmacology & Translational Science 4 (6), 1808-1817, 2021
42021
Success in Navigating Hurdles to Oral Delivery of a Bioactive Peptide Complement Antagonist through Use of Nanoparticles to Increase Bioavailability and In Vivo Efficacy
W Xu, V Kumar, CS Cui, XX Li, AK Whittaker, ZP Xu, MT Smith, ...
Advanced Therapeutics 5 (12), 2200109, 2022
32022
Optimisation of a Microfluidic Method for the Delivery of a Small Peptide
FY Han, W Xu, V Kumar, CS Cui, X Li, X Jiang, TM Woodruff, AK Whittaker, ...
Pharmaceutics 13 (9), 1505, 2021
32021
Success in Navigating Hurdles to Oral Delivery of a Bioactive Peptide Complement Antagonist through Use of Nanoparticles to Increase Bioavailability and In Vivo Efficacy (Adv …
W Xu, V Kumar, CS Cui, XX Li, AK Whittaker, ZP Xu, MT Smith, ...
Advanced Therapeutics 5 (12), 2270030, 2022
2022
An in-vivo pharmacodynamic method to investigate complement C5a receptor antagonists
C Cui, V Kumar, D Gorman, R Clark, J Lee, T Woodruff
MOLECULAR IMMUNOLOGY 141, 125-126, 2022
2022
Sustained-release ketamine-loaded lipid-particulate system: in vivo assessment in mice
W Xu, F Maqbool, V Kumar, JR Falconer, CS Cui, TM Woodruff, K Borges, ...
Drug Delivery and Translational Research, 1-9, 2021
2021
Optimisation of a Microfluidic Method for the Delivery of a Small Peptide. Pharmaceutics 2021, 13, 1505
FY Han, W Xu, V Kumar, CS Cui, X Li, X Jiang, TM Woodruff, AK Whittaker, ...
Nanomedicine Formulations Based on PLGA Nanoparticles for Diagnosis …, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–11